Search Orphan Drug Designations and Approvals
-
Generic Name: | humanized bispecific IgG1 antibody that can simultaneously bind to both programmed death-ligand 1 and cytotoxic T-lymphocyte-associated protein 4 |
---|---|
Date Designated: | 09/02/2020 |
Orphan Designation: | Treatment of Thymic Epithelial Tumors |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Jiangsu Alphamab Biopharmaceuticals Co., Ltd. Bldg. C23, 218 Xinghu Street, SIP SuZhou, Jiangsu China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-